factor vii baxalta powder and solvent for solution for injection - نتائج البحث

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

adynovate 2000 iu powder and solvent for solution for injection

takeda pharmaceuticals (asia pacific) pte. ltd. - rurioctocog alfa pegol [antihaemophilic factor (recombinant), pegylated] - injection, powder, lyophilized, for solution - rurioctocog alfa pegol [antihaemophilic factor (recombinant), pegylated] 2000 iu

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

adynovate 250 iu powder and solvent for solution for injection

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

adynovate 3000 iu powder and solvent for solution for injection

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

adynovate 500 iu powder and solvent for solution for injection

ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

advate 1500iu powder and solvant for solution for injection

takeda malaysia sdn bhd - rfviii (octocog alfa) -

بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prothromplex 600 iu inj. sol. (pwdr. + solv.) i.v. vial

baxalta innovations gmbh - human coagulation factor vii 500 iu; protein c >= 400 iu; human coagulation factor ii 480 iu - 900 iu; human coagulation factor ix 600 iu; human coagulation factor x 600 iu - powder and solvent for solution for injection - 600 iu - protein c 400 iu; human coagulation factor ii; human coagulation factor x 600 iu; human coagulation factor ix 600 iu; human coagulation factor vii 500 iu - coagulation factor ix, ii, vii and x in combination

$FEIBA-NF factor eight inhibitor bypassing fraction 1000U powder for injection vial with diluent vial$ أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

feiba-nf factor eight inhibitor bypassing fraction 1000u powder for injection vial with diluent vial

takeda pharmaceuticals australia pty ltd - factor viii inhibitor bypassing fraction, quantity: 1000 u - injection, powder for - excipient ingredients: sodium citrate dihydrate; sodium chloride - feiba-nf is indicated for routine prophylaxis, control of spontaneous bleeding episodes and use in surgery in haemophilia a or b patients with inhibitors.

$FEIBA-NF factor eight inhibitor bypassing fraction 500U powder for injection vial with diluent vial$ أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

feiba-nf factor eight inhibitor bypassing fraction 500u powder for injection vial with diluent vial

takeda pharmaceuticals australia pty ltd - factor viii inhibitor bypassing fraction, quantity: 500 u - injection, powder for - excipient ingredients: sodium citrate dihydrate; sodium chloride - feiba-nf is indicated for routine prophylaxis, control of spontaneous bleeding episodes and use in surgery in haemophilia a or b patients with inhibitors.

بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

feiba 500 u inj. sol. (pwdr. + solv.) i.v. vial

baxalta innovations gmbh - anti-inhibitor coagulant complex 500 u - powder and solvent for solution for injection - 500 u - factor viii inhibitor bypassing activity 500 iu - factor viii inhibitor bypassing activity

بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

feiba 1 000 u inj. sol. (pwdr. + solv.) i.v. vial

baxalta innovations gmbh - anti-inhibitor coagulant complex 1000 u - powder and solvent for solution for injection - 1000 u - factor viii inhibitor bypassing activity 1000 iu - factor viii inhibitor bypassing activity